Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for InspireMD (NSPR) over the last 11 years, with Q3 2025 value amounting to $269000.0.

  • InspireMD's Other Accumulated Expenses rose 4462.37% to $269000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $269000.0, marking a year-over-year increase of 4462.37%. This contributed to the annual value of $255000.0 for FY2024, which is 3421.05% up from last year.
  • Latest data reveals that InspireMD reported Other Accumulated Expenses of $269000.0 as of Q3 2025, which was up 4462.37% from $241000.0 recorded in Q2 2025.
  • In the past 5 years, InspireMD's Other Accumulated Expenses ranged from a high of $269000.0 in Q3 2025 and a low of $83000.0 during Q3 2021
  • Over the past 5 years, InspireMD's median Other Accumulated Expenses value was $155000.0 (recorded in 2021), while the average stood at $160473.7.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first surged by 18409.09% in 2021, then tumbled by 2941.18% in 2022.
  • Over the past 5 years, InspireMD's Other Accumulated Expenses (Quarter) stood at $155000.0 in 2021, then fell by 16.13% to $130000.0 in 2022, then surged by 46.15% to $190000.0 in 2023, then skyrocketed by 34.21% to $255000.0 in 2024, then rose by 5.49% to $269000.0 in 2025.
  • Its last three reported values are $269000.0 in Q3 2025, $241000.0 for Q2 2025, and $217000.0 during Q1 2025.